Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...